Filing Details
- Accession Number:
- 0000899243-22-025827
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-08 17:20:19
- Reporting Period:
- 2022-07-06
- Accepted Time:
- 2022-07-08 17:20:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286199 | K Joseph Belanoff | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-06 | 800,000 | $2.08 | 800,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-06 | 451,189 | $26.21 | 348,811 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-07-06 | 279,908 | $26.27 | 2,538,218 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 |
| Common Stock | Disposition | 2022-07-07 | 55,111 | $26.26 | 2,483,107 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 |
| No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Acquisiton | 2022-07-06 | 800,000 | $0.00 | 800,000 | $2.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-01-30 | No | 4 | M | Direct |
Footnotes
- These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on July 6, 2022. The options subject to the net exercise were to expire on January 30, 2023.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2022, as amended.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.65. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.41. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- Fully exercisable.
Billionaire Hedge Funds
